Hypoglycemia Treatment
For conscious patients with hypoglycemia (blood glucose ≤70 mg/dL), administer 15-20 g of oral glucose immediately, recheck blood glucose in 15 minutes, and repeat treatment if hypoglycemia persists; for unconscious or severely altered patients, administer glucagon (intranasal or subcutaneous autoinjector preferred) or intravenous dextrose. 1, 2
Immediate Treatment Algorithm
For Conscious Patients (Able to Swallow)
Glucose is the preferred treatment over other carbohydrates because the glycemic response correlates better with glucose content than total carbohydrate content 3, 4, 5. Pure glucose raises blood glucose more effectively than orange juice or milk, since juice contains fructose and milk contains galactose, both less effective than glucose 4.
Dosing specifics:
- Standard dose: 15-20 g of glucose for most adults 3, 4, 1, 5, 2
- Automated insulin delivery users: 5-10 g of glucose (unless hypoglycemia occurs with exercise or significant meal bolus overestimation, then use standard dose) 2, 6
- Children: 10 g for younger children, 15 g for older 7
Expected response:
- 10 g oral glucose raises blood glucose by 40 mg/dL over 30 minutes
- 20 g oral glucose raises blood glucose by 60 mg/dL over 45 minutes
- Glucose levels begin falling again at 60 minutes after ingestion 3, 8
Critical follow-up steps:
- Initial response should occur within 10-20 minutes 3, 4, 1, 5
- Recheck blood glucose at 15 minutes and repeat treatment if still hypoglycemic 1, 2, 6
- Mandatory recheck at 60 minutes as additional treatment is frequently necessary 3, 4
- After recovery, consume a meal or snack to prevent recurrence, especially if insulin or insulin secretagogues are still active 1, 5
For Unconscious or Severely Altered Patients (Unable to Swallow Safely)
Glucagon is the treatment of choice for severe hypoglycemia outside healthcare facilities 1, 2, 6.
Glucagon administration:
- Preferred formulations: Intranasal or ready-to-inject subcutaneous autoinjector (easier administration, more rapid correction) 2
- Dose: 1 mg intramuscular/subcutaneous or intranasal equivalent 7, 9, 10
- Pediatric dosing: 30 mcg/kg subcutaneously (maximum 1 mg) 7
- Expected response: 5-15 minutes 7
- Side effects: Nausea and vomiting are common 7
Alternative for healthcare settings:
- Intravenous dextrose: 10% dextrose solution preferred over 50% 9, 10
- Recent evidence shows no difference in time to recovery between 10%, 25%, and 50% dextrose (all achieve GCS 15 in 6 minutes), but 10% and 25% required lower total doses (10-15 g vs 25 g) 11
- Traditional recommendation: 25-50 mL of 50% dextrose (12.5-25 g glucose) over 2-3 minutes 12
Critical Pitfalls to Avoid
Do NOT add protein to hypoglycemia treatment - it increases insulin secretion and does not prevent subsequent hypoglycemia 3, 8, 6
Do NOT add fat to treatment - it retards the acute glycemic response, delaying recovery 3, 8
Do NOT use glucose gel or orange juice as first-line - less effective than glucose tablets or solution for symptom relief 4
Do NOT administer insulin to someone experiencing hypoglycemia - caregivers must be explicitly educated on this point 2
Glucagon Prescribing Requirements
All individuals at increased risk must be prescribed glucagon 1, 2, 6:
- Anyone on insulin therapy
- Anyone on insulin secretagogues (sulfonylureas, meglitinides)
- History of level 2 hypoglycemia (glucose <54 mg/dL)
- History of level 3 hypoglycemia (severe event with altered mental/physical status requiring assistance)
- Hypoglycemia unawareness
Caregiver education is mandatory - family members, roommates, school personnel, childcare staff, correctional officers, and coworkers must know where glucagon is stored and how to administer it 1, 9, 2, 6. Current glucagon prescribing rates are unacceptably low in practice 2.
Treatment Thresholds
Treat at glucose ≤70 mg/dL (3.9 mmol/L) - this is the hypoglycemia alert value 1, 2, 6
Urgent treatment required at glucose ≤50 mg/dL (2.8 mmol/L) 4
Even glucose 60-80 mg/dL (3.3-4.4 mmol/L) may require management decisions (carbohydrate ingestion, deferring exercise, insulin adjustment) 4
Special Populations
Correctional institutions must have systems for immediate hypoglycemia detection and treatment, with glucose tablets or equivalent readily accessible to security staff supervising at-risk patients 9. Staff should have glucagon available without requiring patient transport to outside facilities 9.
Elderly and young children are particularly vulnerable due to reduced ability to recognize symptoms and communicate needs, requiring more frequent monitoring and individualized approaches 6.
Patients with hypoglycemia unawareness should raise glycemic targets to strictly avoid hypoglycemia for several weeks to partially reverse the condition 1, 2.